UK doctor banned from reversing chemical abortions


Dispatches from the Reproductive Revolution 2. At the request of a leading abortion provider, a doctor in the UK has been banned by the Medical Practitioners Tribunal Service from helping women to reverse the effects of their chemical abortions. He could be deregistered.

As often happens, this story is a tangled one. Bear with us.

During the UK’s first lockdown, abortion providers lobbied to send chemical abortion drugs to women through the postal service. They would never see a doctor; instead, they just took two pills and waited for the foetus to be expelled.

Some women regretted their impulsive decision as soon as they had taken the first pill. For them, Dr Dermot Kearney prescribed progesterone, a hormone for treating natural miscarriages, in an attempt to cancel the effects of the abortifacient, mifepristone. This is an off-label use of progesterone.

He claims that of 73 women, 38 of them managed to hold on to their babies -- a success rate of almost 50%.

According to the Daily Mail, MSI Reproductive Choices, formerly known as Marie Stopes International, filed a complaint. It claimed that Dr Kearney “inappropriately prescribed progesterone to a patient for a use not backed by evidence, failed to present a balanced picture of its benefits and risks, and imposed his anti-abortion beliefs on her.”

Andrea Williams, chief executive of the Christian Legal Centre, said: “Babies are alive today because mothers reached out to Dr Kearney and he provided effective and safe abortion rescue. This ruling punishes the life saver, is deeply wrong and needs to be overturned.”  

Dr Kearney, a cardiologist and emergency physician and the president of the Catholic Medical Association, has been told by the MPTS that “he must not prescribe, administer or recommend progesterone for abortion reversal treatments”. Otherwise, he can continue practicing until the hearing.

Michael Cook is editor of BioEdge   




MORE ON THESE TOPICS | abortion, msi reproductive choices

This article is published by Michael Cook and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

 
 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 
comments powered by Disqus